HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...
Health and Me on MSN
What Is ‘Bluetoothing’? The Alarming Drug Trend Behind Rising HIV Cases
Bluetoothing is a disturbing drug trend where users inject the blood of someone who is already high, hoping to feel the same ...
Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...
A new preclinical study led by researchers at Johns Hopkins University School of Medicine, along with teams from Drexel and ...
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback